Atlanta, GA, United States of America

Himanshu Shah


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Himanshu Shah: Innovator in Reducing Multidrug Resistance

Introduction

Himanshu Shah is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of medical science, particularly in the area of reducing multidrug resistance in cancers and infections. With a total of 3 patents, his work is paving the way for more effective treatments for patients facing drug-resistant conditions.

Latest Patents

Himanshu Shah's latest patents focus on compositions and methods for reducing or eliminating multidrug resistance. One of his notable inventions involves administering a non-ionic amphipathic diester of fatty acids or a reverse poloxamer to patients. This method is particularly effective in cases where cancers or microorganisms exhibit multidrug resistance to chemotherapeutic agents. His innovative approach aims to enhance the efficacy of treatments for patients suffering from these challenging conditions.

Career Highlights

Throughout his career, Himanshu has worked with reputable institutions, including Rush Presbyterian-St. Luke's Medical Center. His experience in these medical environments has allowed him to develop and refine his inventions, contributing to advancements in patient care and treatment options.

Collaborations

Himanshu has collaborated with notable professionals in his field, including John S. Coon and Mannarsamy Balasubramanian. These partnerships have further enriched his research and development efforts, leading to impactful innovations.

Conclusion

Himanshu Shah is a dedicated inventor whose work in reducing multidrug resistance is making a significant difference in the medical field. His innovative methods and compositions hold promise for improving treatment outcomes for patients facing drug-resistant challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…